Blog
Next-generation Sequencing Advancements in the Diagnostic Lab
BlogAgilent are working to increase the utility of NGS in the diagnostics field and in personalized medicine. We recently spoke with Ronda Allen, Head of R&D at Agilent, to learn more about two of Agilent's newest products in this space, the Cancer All-in-one (AIO) panels, and the Magnis NGS Library Prep System.
Read More
Fuelling Innovation in UK Life Sciences
BlogWe spoke to Daniel Rooke, Head of Operations and Legal at Start Codon, to learn more about the company and how they can help early stage healthcare and life science businesses in the UK to get off the ground.
Read More
Easing the "Informatics Bottleneck" Burden in Next-generation Sequencing
BlogTechnology Networks recently spoke with Rosengarten and Raymond Mercier, VP and GM, Molecular Biology, Thermo Fisher Scientific, to learn more about how the co-marketing agreement between Thermo Fisher Scientific and Genialis will help ease the burden of the "informatics bottleneck" for research scientists.
Read More
Translational Research in Clinical Proteomics
BlogIn this article, Gary Kruppa, VP of Proteomics at Bruker Daltonics, explores how proteomic methods can help achieve the ultimate goal of preventing and improving the treatment of disease.
Read More
Illuminating Cancer Cells To Help Guide Surgery
BlogSurgery, when used as a cancer treatment, is a procedure in which a surgeon identifies and removes the cancerous tissue from a patient’s body. We recently spoke with Christopher Barys, CEO at On Target Laboratories to learn more about the novel cancer imaging agents they are currently developing, designed to help surgeons identify and resect cancerous lesions.
Read More
Applying Precision Genomics in Biopharma Drug Development
BlogA recent collaboration between Onconova Therapeutics and Mission will utilize the Mission Bio TapestriⓇ Platform to conduct targeted single-cell DNA analysis for the study of Onconova's novel cancer therapy, Rigosertib. We spoke with Darrin Crisitello, CCO of Mission Bio, to learn more.
Empowering Cancer Patients After Diagnosis
BlogWe recently spoke with Jed Coleman, co-founder of Curve.life, an online service aiming to provide cancer patients with evidence-based information about how they can empower themselves after diagnosis.
Read More
Exploring the Fourth Dimension of Proteome Analysis
BlogRecent developments in MS technology have enabled a fourth dimension of analysis: ion mobility separation. The term "4D proteomics" has been created to describe analysis that incorporates all four dimensions. We interviewed two researchers at the forefront of the proteomics field to learn more about how 4D proteomics approaches are enhancing their research.
10 Things to Note About Manufacturing Viral Vectors
Blog10 things to note about viral vector manufacturing, regarding the complexities and challenges, and the technology that will help drive cell and gene therapy forward. Here we share insights from Pall and Molmed representatives, who are leaders in the fields of bioprocessing and cell and gene therapy.
Read More
Harnessing the Power of Proteins To Unlock Cell and Gene Therapies
BlogWe recently spoke with Paul Wotton, Ph.D., CEO at Obsidian Therapeutics, to gain his insights on the genetically engineered cell-therapy research area, and to learn how Obsidian Therapeutics' cytoDRiVE platform can increases the specificity and safety of such therapies.
Read More
